ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype

BACKGROUND: Neuroendocrine phenotype is commonly associated with therapy resistance and poor prognoses in small-cell neuroendocrine cancers (SCNCs), such as neuroendocrine prostate cancer (NEPC) and small-cell lung cancer (SCLC). Expression levels of current neuroendocrine markers exhibit high case-...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Michelle, Liu, Shiqin, Toland, Angus, Hsu, En-Chi, Hartono, Alifiani B., Alabi, Busola R., Aslan, Merve, Nguyen, Holly M., Sessions, Conner J., Nolley, Rosalie, Shi, Chanjuan, Huang, Jiaoti, Brooks, James D., Corey, Eva, Stoyanova, Tanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667239/
https://www.ncbi.nlm.nih.gov/pubmed/37798372
http://dx.doi.org/10.1038/s41416-023-02448-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667239/
https://www.ncbi.nlm.nih.gov/pubmed/37798372
http://dx.doi.org/10.1038/s41416-023-02448-y

Ejemplares similares